Fine RL - Search Results

1

P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance.

Lee JJ, Hughes CS, Fine RL, Page RL. Lee JJ, et al. Among authors: fine rl. Cancer. 1996 May 1;77(9):1892-8. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1892::AID-CNCR20>3.0.CO;2-U. Cancer. 1996. PMID: 8646690

2

Phase I and pharmacokinetic analysis of high-dose tamoxifen and chemotherapy in normal and tumor-bearing dogs.

Waddle JR, Fine RL, Case BC, Trogdon ML, Tyczkowska K, Frazier D, Page RL. Waddle JR, et al. Among authors: fine rl. Cancer Chemother Pharmacol. 1999;44(1):74-80. doi: 10.1007/s002800050947. Cancer Chemother Pharmacol. 1999. PMID: 10367752

3

P-glycoprotein, multidrug resistance and protein kinase C.

Fine RL, Chambers TC, Sachs CW. Fine RL, et al. Stem Cells. 1996 Jan;14(1):47-55. doi: 10.1002/stem.140047. Stem Cells. 1996. PMID: 8820951 Review.

4

Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, P-glycoprotein.

Lanning CL, Fine RL, Sachs CW, Rao US, Corcoran JJ, Abou-Donia MB. Lanning CL, et al. Among authors: fine rl. J Toxicol Environ Health. 1996 Mar;47(4):395-407. doi: 10.1080/009841096161726. J Toxicol Environ Health. 1996. PMID: 8600291

5

Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha.

Blobe GC, Sachs CW, Khan WA, Fabbro D, Stabel S, Wetsel WC, Obeid LM, Fine RL, Hannun YA. Blobe GC, et al. Among authors: fine rl. J Biol Chem. 1993 Jan 5;268(1):658-64. J Biol Chem. 1993. PMID: 8093247 Free article.

6

Multidrug resistance.

Fine RL. Fine RL. Cancer Chemother Biol Response Modif. 1988;10:73-84. Cancer Chemother Biol Response Modif. 1988. PMID: 2908587 Review.

7

Multidrug resistance.

Fine RL, Chabner BA. Fine RL, et al. Cancer Chemother Biol Response Modif. 1987;9:81-92. Cancer Chemother Biol Response Modif. 1987. PMID: 2908588 Review. No abstract available.

8

Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.

Panella TJ, Smith DC, Schold SC, Rogers MP, Winer EP, Fine RL, Crawford J, Herndon JE 2nd, Trump DL. Panella TJ, et al. Among authors: fine rl. Cancer Res. 1992 May 1;52(9):2456-9. Cancer Res. 1992. PMID: 1533174 Clinical Trial.

9

Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.

Sachs CW, Safa AR, Harrison SD, Fine RL. Sachs CW, et al. Among authors: fine rl. J Biol Chem. 1995 Nov 3;270(44):26639-48. doi: 10.1074/jbc.270.44.26639. J Biol Chem. 1995. PMID: 7592889 Free article.

10

Antiestrogens and steroid hormones: substrates of the human P-glycoprotein.

Rao US, Fine RL, Scarborough GA. Rao US, et al. Among authors: fine rl. Biochem Pharmacol. 1994 Jul 19;48(2):287-92. doi: 10.1016/0006-2952(94)90099-x. Biochem Pharmacol. 1994. PMID: 7914405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters